# Evaluation of Web-based Training to Educate Physicians in the Methods of Interpreting Florbetapir-PET Scans

> **NCT01550549** · NA · COMPLETED · sponsor: **Avid Radiopharmaceuticals** · enrollment: 151 (actual)

## Conditions studied

- Alzheimer Disease
- Mild Cognitive Impairment
- Neurodegenerative Diseases

## Interventions

- **DRUG:** florbetapir F 18

## Key facts

- **NCT ID:** NCT01550549
- **Lead sponsor:** Avid Radiopharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 151 (ACTUAL)
- **Last updated:** 2012-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01550549

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01550549, "Evaluation of Web-based Training to Educate Physicians in the Methods of Interpreting Florbetapir-PET Scans". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01550549. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*